Who's responsible for safety updates? Generics rule debated
This article was originally published in Scrip
Executive Summary
At an all-day FDA meeting on 27 March, where regulators heard five-minute testimonies from about 40 people, it was the pharmaceutical industry versus patients who claimed they were injured from drugs with inadequate warnings.